Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

Abstract Background The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients at early stages of the disease are of high clinic...

Full description

Bibliographic Details
Main Authors: Dijana Djureinovic, Victor Pontén, Per Landelius, Sahar Al Sayegh, Kai Kappert, Masood Kamali-Moghaddam, Patrick Micke, Elisabeth Ståhle
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Cancer
Subjects:
Lung cancer
Tumor markers
Blood
Plasma
Screening
Biomarker
Online Access:http://link.springer.com/article/10.1186/s12885-019-5943-3

Internet

http://link.springer.com/article/10.1186/s12885-019-5943-3

Similar Items